Foundation Medicine and Collaborators to Share Scientific Advances at AACR22 Reinforcing the Power of Genomic Testing in Precision Cancer Care - Business Wire

New studies from Foundation Medicine at AACR22 demonstrate the ability of its portfolio of tests to improve treatment options for patients

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. today announced that the company and its collaborators will present a total of nine studies, including two clinical science symposia prese… [+5820 chars]

full article...